Compare HROW & CCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HROW | CCS |
|---|---|---|
| Founded | 1998 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | N/A | 2014 |
| Metric | HROW | CCS |
|---|---|---|
| Price | $34.10 | $57.68 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 6 |
| Target Price | ★ $71.14 | $70.50 |
| AVG Volume (30 Days) | ★ 924.6K | 213.1K |
| Earning Date | 01-01-0001 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.01% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.86 |
| Revenue | N/A | ★ $4,117,816,000.00 |
| Revenue This Year | $44.68 | N/A |
| Revenue Next Year | $40.71 | $10.84 |
| P/E Ratio | ★ N/A | $11.89 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $20.85 | $50.42 |
| 52 Week High | $54.98 | $76.00 |
| Indicator | HROW | CCS |
|---|---|---|
| Relative Strength Index (RSI) | 27.80 | 25.04 |
| Support Level | $30.55 | $56.72 |
| Resistance Level | $40.64 | $66.55 |
| Average True Range (ATR) | 2.54 | 2.05 |
| MACD | -1.45 | -1.20 |
| Stochastic Oscillator | 2.31 | 9.78 |
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
Century Communities Inc is engaged in the development, design, construction, marketing and sale of single-family attached and detached homes. The company builds and sells homes under its Century Communities and Century Complete brands. Its reportable segments for homebuilding operations are: i) West (California and Washington) ii) Mountain (Arizona, Colorado, Nevada and Utah), iii) Texas, iv) Southeast (Florida, Georgia, North Carolina, South Carolina and Tennessee), v) Century Complete (Alabama, Arizona, Florida, Georgia, Indiana, Kentucky, Michigan, North Carolina, and South Carolina). The company's other reportable segments include: Financial Services and Century Living. The company derives the majority of its revenue from the sale of new homes in the Mountain segment.